Renal and depressor activity of C-natriuretic peptide in conscious monkeys: Effects of enzyme inhibitors

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 3, 1996, Pages 397-401

  Seymour, Andrea Ann ^a   Mathers, Parker D ^a   Abboa Offei, Benoni E ^a   Asaad, Magdi M ^a   Weber, Helen ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Angiotensin converting enzyme; C Type natriuretic peptide; Cyclic GMP; Natriuresis; Neutral endopeptidase EC 3.4.24.11

Indexed keywords

CAPTOPRIL; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; N (2 MERCAPTOMETHYL 3 PHENYLPROPIONYL) BETA ALANINE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

ALANINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CAPTOPRIL; CYCLIC GMP; ENZYME INHIBITORS; FEMALE; KIDNEY; MACACA FASCICULARIS; NATRIURETIC PEPTIDE, C-TYPE; NEPRILYSIN; PROTEINS; SODIUM;

EID: 0029848423     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199609000-00008     Document Type: Article

References (17)

1. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1999;168:863-70.
2. Koller KJ, Lowe DG, Bennett GL, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991;252:120-3.
3. Clavell AL, Stingo AJ, Wei C-M, Heublein DM, Burnett JC Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol 1993;264:R290-5.
4. Stingo AJ, Clavell AL, Aarhus LL. Burnett JC Jr. Cardiovascular and renal actions of C-type natriuretic peptides. Am J Physiol 1992;262:H308-12.
5. Seymour AA, Asaad MM, Abboa-Offei BE, Rovnyak PL, Fennell S, Rogers WL. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats. J Pharmacol Exp Ther 1992; 262:60-70.
6. Zhoa J, Ardaillow N, Lu C-Y, et al. Characterization of C-type natriuretic receptors in human mesangial cells. Kidney Int 1994;46:717-25.
7. Kenny AJ, Bourne A, Ingram J. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J 1993;291:83-8.
8. Scalese RJ, DeForrest JM, Hammerstone S, Parente E, Burkett DE. Long term vascular catheterization of the cynomolgus monkey. Lab Anim Sci 1990;40:530-2.
9. Seymour AA. The pharmacology of SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11. Cardiovasc Drug Rev 1991;9:285-98.
10. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F. PCR localization of C-type natriuretic peptide and B-type receptor mRNAs in rat nephron segments. Am J Physiol 1994;267:F215-22.
11. Fournié-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension. Proc Natl Acad Sci USA 1994;91:4072-5.
12. French JF, Flynn GA, Giroux EL, et al. Characterization of a dual inhibitor of angiotensin 1-converting enzyme and neutral endopeptidase. J Pharmacol Exp Ther 1994;268:180-6.
13. Robl JA, Simpkins LM, Stevenson J, et al. Dual metalloprotease inhibitors. 1. Constrained peptidomimetics of mercaptoacyl dipeptides. Bioorg Med Chem Lett 1994;4:1789-94.
14. Vera WG, Fournié-Zaluski M-C, Pham I, Laboulandine I, Roques B-P, Michel J-B. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. J Pharmacol Exp Ther 1995;272:343-51.
15. Bralet J, Marie C, Mossiat C, Lecomte J-M, Gros C, Schwartz J-C. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin 1-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. J Pharmacol Exp Ther 1994;270:8-14.
16. Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. J Pharmacol Exp Ther 1993;266:872-83.
17. Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors. J Pharmacol Exp Ther 1996;276:708-13.